Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Safe Supply Announces Strategic Expansion into AI-Powered Healthcare Solutions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Thallion Pharmaceuticals Inc
V.TLN
Healthcare
Biotechnology
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:TLN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(33)
•••
dreamer05
X
View Profile
View Bullboard History
Comment by
dreamer05
on Jan 23, 2012 10:04am
RE: Target = $3
EOIM, true according to your estimate and the information published so far. However, the sp of tln has been hanging around below 15 cents for years waiting for the outcome of the trial. In fact after&
...more
(0)
•••
EOIM
X
View Profile
View Bullboard History
Post by
EOIM
on Jan 22, 2012 11:26pm
Target = $3
Strong BUY..............
Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted Therapy
posted May 31, 2024 9:00am by
Numinus Wellness Inc
-
|
"We are pleased to have received approval for this study, which will be the first of its kind to investigate the viability of a group therapy model, establish the best methods for MDMA group therapy, and add to the existing research supporting its safe use ...read more
(0)
•••
EOIM
X
View Profile
View Bullboard History
Post by
EOIM
on Jan 19, 2012 12:29pm
Germany Hit By ECOLI - EU
https://ec.europa.eu/food/food/coli_outbreak_germany_en.htm
(0)
•••
EOIM
X
View Profile
View Bullboard History
Comment by
EOIM
on Jan 19, 2012 12:19pm
RE: More Questions for the Board
Ok, I found the answer here: https://en.wikipedia.org/wiki/Orphan_drug Additinal insight would be appreciated.
(0)
•••
EOIM
X
View Profile
View Bullboard History
Post by
EOIM
on Jan 19, 2012 12:17pm
More Questions for the Board
I am not a biotech investor but tis one caught my eyes after the Danny article. Can someone knowledgable describe the advantages of assigning an Orphan Drug Designation to Thalliums Shagamabs drug?
(0)
•••
Sharkbite5599
X
View Profile
View Bullboard History
Comment by
Sharkbite5599
on Jan 19, 2012 12:10am
RE: RE: LFB To Pay 95 million Euros!!!
hey thirsty nicely said and im a retard too,hoping to hitting a home run here Danny will probably do a follw up soon.
(0)
•••
vern117
X
View Profile
View Bullboard History
Comment by
vern117
on Jan 18, 2012 11:21pm
RE: Euro version of the news
Thallion and LFB complete patient enrollment of Phase II Shigatec trial Montréal, Les Ulis, January 9, 2012 – Thallion Pharmaceuticals Inc. (TSX: TLN) and LFB Biotechnologies announced today that
...more
(0)
•••
thirstytrader
X
View Profile
View Bullboard History
Comment by
thirstytrader
on Jan 18, 2012 10:26pm
RE: LFB To Pay 95 million Euros!!!
1 EUR = 1.3 CAD so 95 MM Euro = 123 MM$ CAD 123 MM$ CAD / 35MM Shares = 3.52$ /shares CASH PLUS they have 16% of Caprion with recent annual sales of 42 MM$ PLUS they still own the rights for the whole
...more
(0)
•••
EOIM
X
View Profile
View Bullboard History
Post by
EOIM
on Jan 18, 2012 9:30pm
LFB To Pay 95 million Euros!!!
I found it quite amazing after doing some DD on this company. What I found remrkable are the following; - LFD will pay TLN 95 million euro (more than $3 per share) for getting the licensing right for
...more
(0)
•••
thirstytrader
X
View Profile
View Bullboard History
Post by
thirstytrader
on Jan 18, 2012 6:14pm
Euro version of the news
https://www.lfb.fr/EN/Thallion%20and%20LFB%20complete%20patient%20enrollment%20of%20Phase%20II%20Shigatec%20trial.html
(0)
•••
thirstytrader
X
View Profile
View Bullboard History
Post by
thirstytrader
on Jan 18, 2012 11:35am
DANNY DEADLOCK did a great job
getting attention to this stock! For once the market is realizing the potential...
(0)
•••
fisherman211
X
View Profile
View Bullboard History
Comment by
fisherman211
on Jan 16, 2012 3:36pm
RE: RE: Nice finish
Bidding @ .15...albeit weak is nice to see...and nothing on the alphoooo tooooo
(0)
•••
thirstytrader
X
View Profile
View Bullboard History
Comment by
thirstytrader
on Jan 14, 2012 12:29pm
RE: Nice finish
I agree, lack of volume but less selling pressure from NBF and more interest from TD, we closed on the week's high, might mean a nice opening monday... we'll see:)
(0)
•••
fisherman211
X
View Profile
View Bullboard History
Post by
fisherman211
on Jan 13, 2012 9:56pm
Nice finish
The week ended nicely....not too radica,l with fairly strong biding. Nice and easy. Just need to pump up the volume alittle. Good luck all.....fishy
(33)
•••
dreamer05
X
View Profile
View Bullboard History
Comment by
dreamer05
on Jan 12, 2012 9:45am
RE: Eculizumab DOES NOT WORK WELL
From what I knew, and from information I have learned so far there is no drug available in the market that can treat e-coli infections, not even that Eculijumab stuff. So my question is
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Nanalysis Scientific Corp. Announces First Quarter 2024 Results